Development of novel chitosan derivatives as micellar carriers of taxol

被引:148
作者
Miwa, A
Ishibe, A
Nakano, M
Yamahira, T
Itai, S
Jinno, S
Kawahara, H
机构
[1] Taisho Pharmaceut Co Ltd, Pharmaceut Res Labs, Pharmaceut Lab, Ohmiya, Saitama 3308530, Japan
[2] Nippon Suisan Kaisha Ltd, Cent Res Lab, Hachioji, Tokyo 1920906, Japan
关键词
taxol; N-lauryl-carboxymethyl-chitosan (LCC); chitosan; polymer micelle; solubility; nanoparticle; hemolysis; antitumor activity;
D O I
10.1023/A:1011901921995
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To develop an intravenous injectable carrier composed of chitosan derivatives for taxol. Methods. A chitosan with lauryl groups attached to amino groups to provide the hydrophobic moieties and, carboxymethyl groups attached to hydroxy groups to provide the hydrophilic moieties (N-lauryl-carboxymethyl-chitosan = LCC), was newly synthesized. The solubility of taxol in LCC micelles in aqueous solution was examined. The hemolysis test of LCC and the growth inhibition experiment of taxol-loading micelle using KB cells were also performed as in vitro assay. Results. It was found that LCC solubilized taxol by forming micelles with particle sizes less than 100 nm. This particle size was considered effective for passive targeting for tumors. The concentration of taxol in the micellar solution was very high, with a maximum of 2.37 mg/mL. This maximum was 1000 times above that in a saturated solution of taxol at pH 7.4. Hemolysis testing as an in vitro assay indicated that LCC was safer than Polysorbate 80 (TO-10M) as intravenous surfactant in terms of induction of membrane damage. As judged by cytostatic activity against KB cells, taxol retained activity even when included in LCC micelles. LCC-entrapped taxol was more effective in cytostatic activity than free taxol in low concentrations. Conclusions. The results of solubilization capacity examination, hemolysis testing, and cytostatic activity suggest that LCC may be useful as a carrier of taxol.
引用
收藏
页码:1844 / 1850
页数:7
相关论文
共 21 条
[1]   SELF-AGGREGATES OF HYDROPHOBIZED POLYSACCHARIDES IN WATER - FORMATION AND CHARACTERISTICS OF NANOPARTICLES [J].
AKIYOSHI, K ;
DEGUCHI, S ;
MORIGUCHI, N ;
YAMAGUCHI, S ;
SUNAMOTO, J .
MACROMOLECULES, 1993, 26 (12) :3062-3068
[2]   A MIXED MICELLAR FORMULATION SUITABLE FOR THE PARENTERAL ADMINISTRATION OF TAXOL [J].
ALKANONYUKSEL, H ;
RAMAKRISHNAN, S ;
CHAI, HB ;
PEZZUTO, JM .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :206-212
[3]  
ALLEY MC, 1988, CANCER RES, V48, P589
[4]   Solubility and stability of taxol: Effects of buffers and cyclodextrins [J].
Dordunoo, SK ;
Burt, HM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) :191-201
[5]  
GREENWALD RB, 1994, Patent No. 20089
[6]  
INOUE Y, 1982, REP PROGR POLYM PHYS, V25, P759
[7]  
ISHIKAWA Y, 1991, Journal of Biomaterials Science Polymer Edition, V2, P53, DOI 10.1163/156856291X00052
[8]  
KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
[9]  
Onetto N, 1993, J Natl Cancer Inst Monogr, P131
[10]   NOVEL TAXOL FORMULATIONS - PREPARATION AND CHARACTERIZATION OF TAXOL-CONTAINING LIPOSOMES [J].
SHARMA, A ;
STRAUBINGER, RM .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :889-896